Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer

NCT03542877 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Oral Tablet: Cabozantinib

Sponsor

Academic Thoracic Oncology Medical Investigators Consortium

Collaborators

[object Object]